News | March 03, 2023
Pharmapack 2023 a pivotal moment for sustainability in drug delivery and packaging
Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
The new sterile filling line meets cGMP aseptic filling regulatory requirements
APAC to see a reduction in imported surgical robotics
The pharma laboratory is fully equipped with all the machinery needed to support formulation development, resolve technical challenges, and provide customer demonstrations
Further, ICAR-IVRI have jointly developed a Lumpy Skin Disease vaccine and as soon as the technology is made available, Hester will acquire the same and manufacture and commercialize the Lumpy Skin disease Vaccine
Cytel has now established entities in Australia, Shanghai, Beijing, and Singapore, and plans to expand into Seoul and Tokyo in the coming years.
The capital expansion program commenced in June 2022 and is expected to complete in 2024
Company will invest approximately ¥16 billion to increase production capacity by approximately 70% to ensure a stable supply
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction
Subscribe To Our Newsletter & Stay Updated
